Linde (NASDAQ:LIN) has outperformed the market over the past 20 years by 2.02% on an annualized basis producing an average annual return of 11.06%. Currently, Linde has a market capitalization of $219.15 billion.
Linde plc · NASDAQ
Linde (NASDAQ:LIN) has outperformed the market over the past 20 years by 2.02% on an annualized basis producing an average annual return of 11.06%. Currently, Linde has a market capitalization of $219.15 billion.
Argus Research analyst Alexandra Yates maintains Linde (NASDAQ:LIN) with a Buy and lowers the price target from $563 to $538.
Some companies grow quietly because their customers physically cannot leave them, and four stocks have turned that structural trap into decades of compounding returns most investors overlook entirely.
AMD, Linde and Amgen highlight AI demand, contracted growth and drug launches, while supply, margin and pipeline risks remain key factors.
Hydrogen energy stocks split: Bloom Energy leads on momentum, while Linde, Air Products and Cummins lag despite solid fundamentals. Learn more.
While Dow and LyondellBasell handed shareholders painful dividend cuts, a handful of chemical names kept raising their payouts through the same downcycle.
The ProShares S&P 500 Dividend Aristocrats ETF trails SPY YTD, but 20 individual Aristocrats are outperforming the ETF. Check out the Aristocrats list here.
Top 10 dividend growth stocks with 25+ years of raises and 8%+ 5-year DGRs.
FuelCell Energy's Tri-gen system combines hydrogen, electricity and water output to serve transportation and industrial energy needs.
Linde (LIN) is back in focus after Zacks highlighted the stock’s year to date outperformance versus the Chemical Specialty industry, pointing to its contract-heavy model and growing electronics exposure.
LIN is up +0.54%. Possible market-relevant factors below — each is coincident evidence, not a confirmed cause.